1-3 of 3
Qunli Xu
Close
Sort by
Journal Articles

Proline-Rich Tyrosine Kinase (Pyk2) Promotes Tumor Progression in Multiple Myeloma (MM) and Represents a Novel Target for Therapy in MM

Yu Zhang, MD, Yong Zhang, PhD, Yuji Mishima, PhD, Michele Moschetta, MD, Wenjing Zhang, MD, Patricia Maiso, PhD, Antonio Sacco, BS, Yosra Aljawai, MS, Ilyas Sahin, MD, Michaela R. Reagan, PhD, Jennifer E. Ring, Winnie F. Tam, PhD, Qunli Xu, PhD, Jonathan A. Pachter, PhD, Aldo M Roccaro, MD PhD, Irene M. Ghobrial, MD
Journal: Blood
Blood (2014) 124 (21): 2101.
https://doi.org/10.1182/blood.V124.21.2101.2101
Published: 2014
Journal Articles

VS-4718, a Potent Focal Adhesion Kinase (FAK) Inhibitor, Exhibits Anticancer Activity in Leukemia Models in Vitro and in Vivo

Winnie F. Tam, PhD, Jennifer E. Ring, Anthony F. Trombino, PhD, David T. Weaver, PhD, Jonathan A. Pachter, PhD, Mahesh Padval, PhD, Qunli Xu, PhD
Journal: Blood
Blood (2014) 124 (21): 982.
https://doi.org/10.1182/blood.V124.21.982.982
Published: 2014
Journal Articles

Pyk2 promotes tumor progression in multiple myeloma

Yu Zhang, Michele Moschetta, Daisy Huynh, Yu-Tzu Tai, Yong Zhang, Wenjing Zhang, Yuji Mishima, Jennifer E. Ring, Winnie F. Tam, Qunli Xu, Patricia Maiso, Michaela Reagan, Ilyas Sahin, Antonio Sacco, Salomon Manier, Yosra Aljawai, Siobhan Glavey, Nikhil C. Munshi, Kenneth C. Anderson, Jonathan Pachter, Aldo M. Roccaro, Irene M. Ghobrial
Journal: Blood
Blood (2014) 124 (17): 2675–2686.
https://doi.org/10.1182/blood-2014-03-563981
Published: 2014
Includes: Supplemental data